The differential effect played by KIR AA genotype in the above three studies might be partly resulted from the distinct maturation stages and the nonoverlapping subsets of lineage markers and fusion proteins, such as HLA class I molecules, expressed by various myeloid neoplasms [16–18]. The gene discussed is KIR3DL1; the disease is myeloid neoplasm.